⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT September 3, 2026

Envarsus 1 mg Retardtabletten 1 mg (Retardtablette)

📷 Wikipedia: Tacrolimus · Source
Envarsus 1 mg Retardtabletten 1 mg (Retardtablette)
📷 Wikipedia: Tacrolimus · Source

🚫 Parallel export ban active

ATC
L04AD02
Reason
Kapazitätsengpässe bei der Herstellung
Marketing authorisation holder
Chiesi Farmaceutici S.p.A., Via Palermo 26/a, 43122 Parma, Italien
Affected packs
60 Stück Blisterpackung, Schachtel [eingeschränkt verfügbar, since 2026-09-03, resupply 2026-11-09]
⚠️
Shortage ongoing
TACROLIMUS MONOHYDRAT is currently in short supply in AT.
📈 Timeline
7 days active so far
September 4, 2026 September 10, 2026
A plain-language summary will appear here shortly. Read the official notice below.
🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

🚫 Parallel export ban active · ATC: L04AD02 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Chiesi Farmaceutici S.p.A., Via Palermo 26/a, 43122 Parma, Italien · Affected packs: 60 Stück Blisterpackung, Schachtel [eingeschränkt verfügbar, since 2026-09-03, resupply 2026-11-09]

First published
September 3, 2026
Last refreshed by us
14 hours ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this medicine shortage alert about?
Envarsus 1 mg Retardtabletten 1 mg (Retardtablette). 🚫 Parallel export ban active · ATC: L04AD02 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Chiesi Farmaceutici S.p.A., Via Palermo 26/a, 43122 Parma, Italien · Affected packs: 60 Stück Blisterpackung, Schachtel [eingeschränkt verfügbar, since...
When was this alert issued?
This alert was issued on September 3, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.